Molecular Biology Enzymes Market Forecasts to 2030 - Global Analysis By Product (Enzymes, Kits & Reagents, DNA Extraction, Isothermal Amplification and Other Products), Application, End User and By Geography

According to Stratistics MRC, the Global Molecular Biology Enzymes Market is accounted for $20.6 billion in 2023 and is expected to reach $59.0 billion by 2030 growing at a CAGR of 16.2% during the forecast period. In molecular biology, enzymes are specialized proteins that function as catalysts to quicken and ease metabolic processes in living things. They function by reducing the activation energy needed for a certain chemical reaction to take place, which speeds up these reactions without consuming any resources or changing them in the process. Because they are made to catalyze certain processes or groups of related events, enzymes are extremely specialized.

According to a survey conducted by the World Health Organization, approximately 12,368 individuals were positive for influenza viruses, of which 8,423 (68.1%) were typed as influenza A and 3,945 (31.9%) as influenza B.

Market Dynamics:

Driver:

Increasing amount of genomic projects

The genesis and progression of illnesses such immune system disorders, metabolic diseases, cancer, and inborn genetic disorders are significantly influenced by gene mutations. Research in a number of areas, including illness treatment, customized medicine, and microbial genetics, is advanced by the growing number of genome projects being undertaken worldwide and the declining costs associated with genetic analysis. The market is anticipated to be driven by these procedures, which call for the employment of a variety of enzymes and reagents.

Restraint:

Limited reimbursements for genetic testing

Reimbursement limitations limit the availability of specific molecular biology enzymes needed for genetic testing. Good enzymes can be costly; if reimbursements do not cover the entire cost, labs or research centers may choose to use less expensive substitutes, which may reduce test accuracy or efficiency. Research and development attempts to create newer, more efficient enzymes are hampered by limited reimbursement, which is hampering the growth of the market.

Opportunity:

Rising advancements

The need for specialized enzymes is driven by ongoing advances in molecular biology research as well as the necessity of enzymes for a variety of applications in industries including proteomics, genomics, and recombinant DNA technology. Additionally, advances in recombinant DNA, protein engineering, and enzyme engineering result in the production of new enzymes with enhanced characteristics, which propels market expansion.

Threat:

Regulatory hurdles

Strict regulatory oversight is frequently imposed on enzymes utilized in molecular biology, particularly when these enzymes are used in clinical or medical contexts. Ensuring compliance and meeting regulatory requirements may be costly and time-consuming procedures. It can be costly and time-consuming to comply with regulatory requirements and go through the approval procedures for new enzymes or changes. This is the main factor limiting the market's expansion.

COVID-19 Impact:

The focus of research goals moved significantly from other fields of molecular biology study to COVID-19-related investigations. This has an effect on the market for certain enzyme varieties utilized in various studies and applications. The supply chain experienced major interruptions as a result of manpower constraints, transit restrictions, and lockdowns. This has an impact on the availability of various lab supplies including enzymes used in molecular biology.

The kits & reagents segment is expected to be the largest during the forecast period

The kits & reagents segment is expected to be the largest during the forecast period. This can be attributed to the vast availability of these products in the market space, novel developments, and continuous product launches from key players. Enzymes are expected to rise at the quickest rate over the projection period due to the ongoing development of cloning technology as a standard laboratory procedure and the expanding field of molecular biology. This has allowed the manufacturers and suppliers to provide multiple enzymes for nucleic acid manipulation.

The pharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period. This can be attributed to the widespread adoption of molecular biology products that facilitate workflow. The convenience and effectiveness of these goods during the pharma and biotech businesses' research for drug candidates, customized medicine, or diagnostics enhances their offers and, as a result, increases revenues. In the upcoming years, the market will be driven by the widespread adoption of molecular technologies by businesses throughout the R&D and clinical trials phases.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to increase in research funds in clinical & translational research and surge in number of biotechnology & pharmaceutical companies in nations. Research on preventive and treatment options is growing due to the prevalence of chronic illnesses in all age groups and the ubiquity of cancer in the community. The presence of well-established players ease of adoption of new technologies are considered to be the major factors fueling revenue generation in this region.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period the presence of bio-clusters in the nations. Manufacturers of molecular biology have found great development potential due to the deficient healthcare systems, large population, increased need for focused therapeutics, and quick economic expansion. Further encouraging western corporations to introduce new goods and win market dominance in these countries is the rising spending power of these nations, which in turn has increased market revenue.

Key players in the market:

Some of the key players in Molecular Biology Enzymes market include Illumina, Inc., Merck KGAA, Bioline Technologies, Promega Corporation, Rockland Immunochemicals, Qiagen, Agilent Technologies, Inc., Jena Bioscience GmbH, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Takara Bio, Inc., LGC Limited and Bausch Health Companies Inc.

Key Developments:

In October 2022, Illumina Inc. announced strategic research collaboration with AstraZeneca, a global, science-led biopharmaceutical company, to accelerate drug target discovery by combining their strengths in artificial intelligence (AI) based genome interpretation and genomic analysis techniques along with industry expertise.

In September 2021, Thermo Fisher Scientific has announced the launch of its fully-automated analyzers specifically designed for enzyme assay applications. The systems combine hardware and new custom-designed software to deliver fully automated incubation settings, reagent additions and precise measurement calculations, all at the touch of a button.

Products Covered:

• Enzymes
• Kits & Reagents
• DNA Extraction
• Isothermal Amplification
• Other Products

Applications Covered:

Polymerase Chain Reaction (PCR)

• Epigenetics
• Cloning
• Sequencing
• Restriction Digestion
• Synthetic Biology
• Other Applications

End Users Covered:

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centres
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances